Sitemap - 2024 - Mendelspod

Surprise: Our Most Popular Show of 2024 Was on Genomic AI

Genome Informatics in the Age of AI With Ben Busby, DNAnexus

New Startup Launches Epigenetic Screening: Mohamad Takwa, CEO, Epigenica

AI Powered Multiomics: Joachim Schmid on Data Analysis at Illumina

Renowned GI Oncologist Discusses MRD Testing and the Future of Cancer Detection

Precision Medicine Then and Now: We Talk with the Retiring President of the Personalized Medicine Coalition, Ed Abrahams

MicroRNA: A New Era in Biomarker Discovery with Tim Williams and Paola Ulivi

Somatic Genomics: A Revolution in Biology with Jacob Rubens

Exploring the Future of Single Cell Technology with Mauro Muraro, CEO, Single Cell Discoveries

AI Powered Multiomics: Joachim Schmid on Data Analysis at Illumina

Grail and Verily Alum on Billion Dollar Startup Bringing AI to Drug Development: A Discussion with Vik Bajaj

Singular Genomics Introduces a Dual-Purpose Platform Capable of Both NGS and Spatial Multiomics: Drew Spaventa, CEO & Founder

The Evolving Future of Genetic Counseling with Ellen Matloff, CEO, MyGeneCounsel

As Sequencing Continues to Scale, Volta Labs Improves Sample Prep: Udayan Umapathi, CEO

What’s Next for Large-Scale Proteomics? With Chris Whelan, Janssen

Will this At-Home Blood Collection Device Transform Medicine? Ben Casavant, Tasso

Geneticist Kevin Mitchell Attempts to Naturalize Free Will in New Book

ctDNA Testing Could Lead to New Ways of Staging Cancer Patients, Says Ben Weinberg, MedStar Georgetown

New Approaches to Biology Headline our New Season

14th Season Opener: Michael Levin on ‘The New Biology’

The Success of ctDNA Testing in Colorectal Cancer: Adham Jurdi, Natera

Henrik Zetterberg on the Current Excitement Around Alzheimer’s Research

The Reboot of Consumer Genomics? with Kian Sadeghi, Nucleus Genomics

From Geospatial to Biospatial: Avi Veidman of Nucleai

New Proteomics Technology Brings Unprecedented Sensitivity and Scale: Yuling Luo, CEO, Alamar Bio

Diagnostic Trends in 2024 with Mara Aspinall, Illumina Ventures

The Actionable Epigenome with Bret Barnes, Illumina

Not All Prenatal Screens Are the Same: Jennifer Hoskovec, Billion to One

Harvard's Marc Lipsitch on the New White House Policy Regulating Risky Pathogen Research

Liquid Biopsy Goes Beyond Cancer: Diana Abdueva and Maggie Louie, Aqtual

Cell Therapy Will Transform Medicine as We Know It, Says Jason Bock, CTMC

Two Industry Leaders on Dealing with the Growing Complexity of Genomic Cancer Data

Single Cell Spatial Proteomics with Filip Karlsson, Pixelgen

The Precision Medicine Optimist: Damon Hostin, Illumina

It's Happening. FDA Issues Final Rule for Regulating LDTs

An Ethics First Approach to Genetic Research and Drug Development with Sarah LeBaron von Baeyer

How Do You Train Genomics AI? On Natural Selection Itself, Says VP of Illumina’s AI Lab, Kyle Farh

The Pre-Symptomatic Space with Patrick Short, Sano Genetics

Systemwide Implementation of Precision Medicine at UCHealth with David Kao

Is this New Tech a Game Changer for Spatial Biology?

Synthetic Biology in 2024 with John Cumbers

Illumina Scales Variant Calling and Genome Interpretation to Improve Gap in Genetic Testing with Sam Strom

The Renaissance in DNA Synthesis Continues: Cosimo Ducani, CEO, Moligo

Jennifer Wipf of Ginkgo Bioworks on RNA Therapeutics and Cell Therapy

Precision Medicine for Dogs: Christina Lopes, OneHealth

Taking Gene Therapy to the Next Level: Rahul Kakkar of Tome

Christian Henry of PacBio on Long Reads at Scale, Next Moves

Robert Michel, Editor at The Dark Report, on Gap in Genetic Testing

Turning to Next Gen Proteomics for Novel Biomarkers: Jon Brudvig and Bruce Wilcox

What Have We Learned from the Brain Map Project So Far? with Tom Nowakowski, UCSF

Quality Healthcare Should Not Depend on Which Book Club You Attend, Karen Tumulty of the Washington Post

Real Probiotics: Colleen Cutcliffe, CEO, Pendulum Therapeutics

Todd Druley of Mission Bio on Single Cell Multi-Omics